In a policy change announced March 19, the Centers for Medicare & Medicaid Services has expanded Medicare coverage for home blood testing of prothrombin time (PT) International Normalized Ratio (INR). As a result, coverage will extend to beneficiaries using the drug warfarin, an anticoagulant medication, for chronic atrial fibrillation or venous thromboembolism.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

March 31, 2008 - Table of Contents

NIR March 31, 2008 (full PDF issue)

Senate, House Bills Would Block July 1 Cut in Physician Fees

House Energy & Commerce Committee Approves Overhaul of CLIA Cytology PT

Current CLIA ‘Hot Spots’ & What They Mean for Labs

Connecticut, New York to Get New Medicare Part A/B Contractor

Coverage Expanded for Home Testing for Anticoagulant Therapy